Antiapoptotic	0	13	O
effect	14	20	O
of	21	23	O
coagulation	24	35	B-Gene_or_gene_product
factor	36	42	I-Gene_or_gene_product
VIIa	43	47	I-Gene_or_gene_product
.	47	48	O

Binding	50	57	O
of	58	60	O
factor	61	67	B-Gene_or_gene_product
VIIa	68	72	I-Gene_or_gene_product
(	73	74	O
FVIIa	74	79	B-Gene_or_gene_product
)	79	80	O
to	81	83	O
its	84	87	O
cellular	88	96	O
receptor	97	105	O
tissue	106	112	B-Gene_or_gene_product
factor	113	119	I-Gene_or_gene_product
(	120	121	O
TF	121	123	B-Gene_or_gene_product
)	123	124	O
was	125	128	O
previously	129	139	O
shown	140	145	O
to	146	148	O
induce	149	155	O
various	156	163	O
intracellular	164	177	O
signaling	178	187	O
events	188	194	O
,	194	195	O
which	196	201	O
were	202	206	O
thought	207	214	O
to	215	217	O
be	218	220	O
responsible	221	232	O
for	233	236	O
TF	237	239	B-Gene_or_gene_product
-	239	240	O
mediated	240	248	O
biologic	249	257	O
effects	258	265	O
,	265	266	O
including	267	276	O
angiogenesis	277	289	O
,	289	290	O
tumor	291	296	B-Pathological_formation
metastasis	297	307	O
,	307	308	O
and	309	312	O
restenosis	313	323	O
.	323	324	O

To	325	327	O
understand	328	338	O
the	339	342	O
mechanisms	343	353	O
behind	354	360	O
these	361	366	O
processes	367	376	O
,	376	377	O
we	378	380	O
have	381	385	O
examined	386	394	O
the	395	398	O
effect	399	405	O
of	406	408	O
FVIIa	409	414	B-Gene_or_gene_product
on	415	417	O
apoptosis	418	427	O
.	427	428	O

Serum	429	434	B-Organism_substance
deprivation	435	446	O
-	446	447	O
induced	447	454	O
apoptosis	455	464	O
of	465	467	O
BHK	468	471	B-Cell
(	471	472	I-Cell
+	472	473	I-Cell
TF	473	475	I-Cell
)	475	476	I-Cell
cells	477	482	I-Cell
was	483	486	O
characterized	487	500	O
by	501	503	O
apoptotic	504	513	O
blebs	514	519	O
,	519	520	O
nuclei	521	527	B-Cellular_component
with	528	532	O
chromatin	533	542	B-Cellular_component
-	542	543	O
condensed	543	552	O
bodies	553	559	O
,	559	560	O
DNA	561	564	O
degradation	565	576	O
,	576	577	O
and	578	581	O
activation	582	592	O
of	593	595	O
caspase	596	603	B-Gene_or_gene_product
3	604	605	I-Gene_or_gene_product
.	605	606	O

FVIIa	607	612	B-Gene_or_gene_product
markedly	613	621	O
decreased	622	631	O
the	632	635	O
number	636	642	O
of	643	645	O
cells	646	651	B-Cell
with	652	656	O
apoptotic	657	666	O
morphology	667	677	O
and	678	681	O
prevented	682	691	O
the	692	695	O
DNA	696	699	O
degradation	700	711	O
as	712	714	O
measured	715	723	O
by	724	726	O
means	727	732	O
of	733	735	O
TdT	736	739	B-Gene_or_gene_product
-	739	740	O
mediated	740	748	O
dUTP	749	753	B-Drug_or_compound
nick	754	758	O
end	759	762	O
labeling	763	771	O
(	772	773	O
TUNEL	773	778	O
)	778	779	O
.	779	780	O

The	781	784	O
antiapoptotic	785	798	O
effect	799	805	O
of	806	808	O
FVIIa	809	814	B-Gene_or_gene_product
was	815	818	O
confirmed	819	828	O
by	829	831	O
the	832	835	O
observation	836	847	O
that	848	852	O
FVIIa	853	858	B-Gene_or_gene_product
attenuated	859	869	O
caspase	870	877	B-Gene_or_gene_product
3	878	879	I-Gene_or_gene_product
activation	880	890	O
.	890	891	O

FVIIa	892	897	B-Gene_or_gene_product
-	897	898	O
induced	898	905	O
antiapoptotic	906	919	O
effect	920	926	O
was	927	930	O
dependent	931	940	O
on	941	943	O
its	944	947	O
proteolytic	948	959	O
activity	960	968	O
and	969	972	O
TF	973	975	B-Gene_or_gene_product
but	976	979	O
independent	980	991	O
of	992	994	O
factor	995	1001	B-Gene_or_gene_product
Xa	1002	1004	I-Gene_or_gene_product
and	1005	1008	O
thrombin	1009	1017	B-Gene_or_gene_product
.	1017	1018	O

FVIIa	1019	1024	B-Gene_or_gene_product
-	1024	1025	O
induced	1025	1032	O
cell	1033	1037	B-Cell
survival	1038	1046	O
correlated	1047	1057	O
with	1058	1062	O
the	1063	1066	O
activation	1067	1077	O
of	1078	1080	O
Akt	1081	1084	B-Gene_or_gene_product
and	1085	1088	O
was	1089	1092	O
inhibited	1093	1102	O
markedly	1103	1111	O
by	1112	1114	O
the	1115	1118	O
specific	1119	1127	O
PI3	1128	1131	B-Gene_or_gene_product
-	1131	1132	I-Gene_or_gene_product
kinase	1132	1138	I-Gene_or_gene_product
inhibitor	1139	1148	O
,	1148	1149	O
LY294002	1150	1158	B-Drug_or_compound
.	1158	1159	O

Blocking	1160	1168	O
the	1169	1172	O
activation	1173	1183	O
of	1184	1186	O
p44	1187	1190	B-Gene_or_gene_product
/	1190	1191	I-Gene_or_gene_product
42	1191	1193	I-Gene_or_gene_product
mitogen	1194	1201	I-Gene_or_gene_product
-	1201	1202	I-Gene_or_gene_product
activated	1202	1211	I-Gene_or_gene_product
protein	1212	1219	I-Gene_or_gene_product
kinase	1220	1226	I-Gene_or_gene_product
(	1227	1228	O
MAPK	1228	1232	B-Gene_or_gene_product
)	1232	1233	O
by	1234	1236	O
the	1237	1240	O
specific	1241	1249	O
mitogen	1250	1257	B-Gene_or_gene_product
-	1257	1258	I-Gene_or_gene_product
induced	1258	1265	I-Gene_or_gene_product
extracellular	1266	1279	I-Gene_or_gene_product
kinase	1280	1286	I-Gene_or_gene_product
(	1287	1288	O
MEK	1288	1291	B-Gene_or_gene_product
)	1291	1292	O
inhibitor	1293	1302	O
,	1302	1303	O
U0126	1304	1309	B-Drug_or_compound
,	1309	1310	O
impaired	1311	1319	O
modestly	1320	1328	O
the	1329	1332	O
ability	1333	1340	O
of	1341	1343	O
FVIIa	1344	1349	B-Gene_or_gene_product
to	1350	1352	O
promote	1353	1360	O
cell	1361	1365	B-Cell
survival	1366	1374	O
.	1374	1375	O

In	1376	1378	O
conclusion	1379	1389	O
,	1389	1390	O
FVIIa	1391	1396	B-Gene_or_gene_product
binding	1397	1404	O
to	1405	1407	O
TF	1408	1410	B-Gene_or_gene_product
provided	1411	1419	O
protection	1420	1430	O
against	1431	1438	O
apoptosis	1439	1448	O
induced	1449	1456	O
by	1457	1459	O
growth	1460	1466	O
factor	1467	1473	O
deprivation	1474	1485	O
,	1485	1486	O
primarily	1487	1496	O
through	1497	1504	O
activation	1505	1515	O
of	1516	1518	O
PI3	1519	1522	B-Gene_or_gene_product
-	1522	1523	I-Gene_or_gene_product
kinase	1523	1529	I-Gene_or_gene_product
/	1529	1530	O
Akt	1530	1533	B-Gene_or_gene_product
pathway	1534	1541	O
,	1541	1542	O
and	1543	1546	O
to	1547	1549	O
a	1550	1551	O
lesser	1552	1558	O
extent	1559	1565	O
,	1565	1566	O
p44	1567	1570	B-Gene_or_gene_product
/	1570	1571	I-Gene_or_gene_product
42	1571	1573	I-Gene_or_gene_product
MAPK	1574	1578	I-Gene_or_gene_product
pathway	1579	1586	O
.	1586	1587	O

